PPT-Gender-specific Results of Atrial Fibrillation Ablation in

John M Mandrola MD Vicky A Swift APRN Kathryn Grace Thorne MS Sean Kettring David E Mann MD Baptist Hospital East Louisville KY No Author has any disclosures   Abstract Introduction. John M Mandrola, MD, Vicky A Swift, APRN, Kathryn Grace Thorne, MS, Sean . Kettring. , David E Mann, MD. Baptist Hospital East, Louisville, KY. .. No Author has any disclosures.  . Abstract. Introduction. An Ov. erview of AF and Treatment Strategies. Jad. . Skaf. , MD. 11/12/15. Southern Regional AHEC . adheres to ACCME Essential Areas and Policies regarding industry support of continuing medical education. All those in a position to control content have disclosed and there are no unresolved conflicts prior to this program. . A . CASE SERIES AND REVIEW OF THE LITERATURE . 1. Lily . K. . Fatula. , BS; . 1,2. William . D. Bolton, MD; . 1,2. Barry . R. Davis, MD; . 1,2. James . E. Stephenson, MD; . 1,2. Sharon . Ben-Or, MD. . erview of AF and Treatment Strategies. Jad. . Skaf. , MD. 11/12/15. Southern Regional AHEC . adheres to ACCME Essential Areas and Policies regarding industry support of continuing medical education. All those in a position to control content have disclosed and there are no unresolved conflicts prior to this program. . Mary N. Healy, MS, ARNP-BC. Heart & Vascular Center of Sarasota. OBJECTIVES. Define the difference between paroxysmal and persistent Atrial Fibrillation. State the CVA risk per year of a 68 . yr. . John Windle MD October 18, 2013. Professor and Chief of Cardiology. University of Nebraska Medical Center. “Ha . ha. . ha. , Biff. Guess what? After we go to the drugstore and the post office, . Con.. Amr Kamal, M.D. Alexandria Main University Hospital. Alexandria- Egypt. ECRA 2010. General Rules . In order to consider AF ablation as a first line therapy, we should have clear and evidence based answers for the following 5 questions:. A . CASE SERIES AND REVIEW OF THE LITERATURE . 1. Lily . K. . Fatula. , BS; . 1,2. William . D. Bolton, MD; . 1,2. Barry . R. Davis, MD; . 1,2. James . E. Stephenson, MD; . 1,2. Sharon . Ben-Or, MD. . <1% of individuals aged 60 to 65 years . 8% to 10% of individuals aged >80 years . Men more than women . White persons more than black persons. Presence and severity of underlying heart disease increases risk . & Minimally Invasive Cox Maze Procedure If you have atrial fibrillation, also called AF, your doctor may discuss several treatment options with you. These options may include surgery. Advanced sur Analyses Using CMS data. Susan R. Heckbert, MD, PhD. University of Washington. Analyses using CMS data. Methods. Strengths & limitations. Application in MESA. Applications outside . MESA. Medicare 5% sample, 100% sample. Nassir F. Marrouche, MD. , Oussama . Wazni. , MD, Tom Greene, PhD, J Michael Dean, MD, Eugene . Kholmovski. , PhD, Moussa Mansour, MD, Hugh Calkins, MD, Francis . Marchlinski. , MD, David Wilber, MD, Gerhard . Freedom . from atrial fibrillation at 12 . months: 63. % of the mitral valve surgery plus ablation group . vs. . 29% of the mitral valve surgery alone group (p < . 0.001). Among . the ablation group, freedom from atrial fibrillation occurred in 61% with PVI vs. 66% with . Edit: October 2018. Content. Why treat Atrial Fibrillation (. AFib. )?. How does concomitant . AFib. therapy benefit your patients?. Who can benefit from concomitant . AFib. therapy? . Concomitant .